✦ LIBER ✦

P-493 A phase II study of weekly innotecan plus capecitabine for chemo-naive patients with advanced non-small cel lung cancer

✍ Scribed by Han, J.; Lee, D.; Lee, S.; Park, C.; Kim, H.; Lee, H.; Lee, J.; Lee, J.

Book ID: 118573398
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 148 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80986-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-230 A phase II study of weekly docetax

P-230 A phase II study of weekly docetaxel plus capecitabine for patients with advanced non-small cell lung cancer (NSCLC)

✍ Han, Ji-Youn; Lee, Dae Ho; Kim, Hae Young; Chun, Jong Ho; Yoon, Sung Min; Lee, H 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Phase II study of weekly irinotecan plus

Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma

✍ Ji-Youn Han; Dae Ho Lee; Sung Young Lee; Chun Gun Park; Hyae Young Kim; Hong Gi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

P-469 Weekly paclitaxel (P), carboplatin

P-469 Weekly paclitaxel (P), carboplatin (C) and innotecan (I), PCI, in patients with chemo-naive advanced non-small cell lung cancer (NSCLC)

✍ Chang, A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A phase II study of weekly docetaxel plu

A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma

✍ Ji-Youn Han; Dae Ho Lee; Hae Young Kim; Eun Kyung Hong; Sung Min Yoon; Jong Ho C 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND Docetaxel is an active agent in advanced nonsmall‐cell lung carcinoma (NSCLC) and demonstrates preclinical and clinical synergism with capecitabine. We conducted the current Phase II study to evaluate the efficacy and safety of the docetaxel/capecitabine combination in ch

A phase I/II study of weekly irinotecan

A phase I/II study of weekly irinotecan combined with weekly cisplatin in patients with advanced non-small cell lung cancer

✍ H. Wataya; Y. Nakanishi; M. Izumi; T. Harada; N. Inoshima; K. Kimotsuki; K. Inou 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

P-45 A phase II study of weekly docetaxe

P-45 A phase II study of weekly docetaxel and cisplatin in patients with advanced non-small-cell lung cancer

✍ Minato, Koichi; Tsuchiya, Satoshi; Ishihara, Shin-ichi; Watanabe, Satoru; Takei, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB